Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia) is Diagnostic Equipment in United States that focus on portfolio business. They cover business area such as portfolio, molecular breast imaging asset, Newport News, Virginia, scanner, acquisition, analysis, software, these system.
-
Portfolio
-
12050 Jefferson Avenue
Newport News, VA 23606
United States
Private
portfoliomolecular breast imaging assetNewport NewsVirginiascanneracquisitionanalysissoftwarethese system
* We use standard office opening hours in near Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Dilon Technologies (Molecular Breast Imaging Assets In Newport News, Virginia) is Diagnostic Equipment business from United States that founded in - ( years old in ), Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia) business is focusing on Portfolio.
Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia) headquarter office and corporate office address is located in 12050 Jefferson Avenue Newport News, VA 23606 United States.
Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia) was founded in United States.
In , Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia) is currently focus on portfolio sector.
Above is snippet of Google Trends for "portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Dilon Technologies (Molecular Breast Imaging Assets in Newport News, Virginia), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
